|
|
|
| Clinical effect analysis of Febuxostat in the treatment of gout combined with hyperlipidemia |
| HUANG Hui-ping HUANG Miao-fang |
| Department of Pharmacy,Guangdong Second People′s Hospital,Guangdong Province,Guangzhou 510317,China |
|
|
|
|
Abstract ObjectiveTo investigate the clinical effect of Febuxostat in the treatment of gout combined with hyperlipidemia.MethodsFrom August 2015 to March 2017,clinical data from 88 gout patients with hyperlipidemia treated in our hospital were selected as objects.They were evenly divided into two groups based on odd or even number,44 cases in each group.In control group Allopurinol was used,while in experimental group Febuxostat was adopted.The levels of blood lipid and blood uric acid,the occurrence of gout and incidence of adverse reactions in the two groups were compared and observed.ResultsBefore treatment,there was no significant difference in blood lipid level or blood uric acid between the two groups(P＞0.05).After therapy,the two indicators mentioned above in the experimental group were lower than those in the control group,the differences were statistically significant(P＜0.05).The incidence of gout and adverse reactions in both groups were compared,the differences were not statistically significant(P＞0.05).ConclusionCompared with Allopurinol,application of Febuxostat in the treatment of gout patients with hyperlipidemia,though similar incidence of adverse reations by the two methods,the effect to decrease the blood lipid level is more remarkable,which can decrease the levels of triglycerides,low-density lipoprotein,and serum total cholesterol.
|
|
|
|
|
|
| [1] |
李威.非布司他与别嘌醇在痛风中应用的短期临床效果对照分析[J].空军医学杂志，2017，33（1）：48-51.
|
| [2] |
张贵江.非布司他和别嘌醇治疗痛风有效性和安全性的meta 分析[J].中国临床药理学杂志，2015，34（2）：73-74.
|
| [3] |
步路标，吕迁洲.小剂量螺内酯联合非布司他治疗早期糖尿病肾病合并高尿酸血症的临床研究[J].中国生化药物杂志，2017，37（5）：323-325.
|
| [4] |
周兴磊，尹忠诚.非布司他治疗慢性肾病伴高尿酸血症患者的临床观察[J].徐州医学院学报，2015，35（12）：870-872.
|
| [5] |
陈勇.非布司他治疗痛风伴高尿酸血症的临床研究[J].四川生理科学杂志，2016，38（2）：84-86.
|
| [6] |
谷丽梅.非布司他治疗痛风伴高尿酸血症疗效观察[J].中国卫生标准管理，2016，7（7）：106-107.
|
| [7] |
苏凡，林静霞，蔡冬梅.非布司他治疗痛风伴高尿酸血症疗效观察[J].齐齐哈尔医学院学报，2016，37（19）：2422-2423.
|
| [8] |
汤艳华，江敏，刘玲，等.非布司他治疗痛风伴高尿酸血症患者的临床研究[J].中国当代医药，2016，23（21）：40-42.
|
| [9] |
韩凤.非布司他治疗痛风伴高尿酸血症的临床效果[J].中国当代医药，2015，22（33）：81-82.
|
| [10] |
刘剑，刘怡.非布司他与别嘌醇治疗痛风伴高尿酸血症的疗效对比分析[J].中国校医，2017，31（3）：228-229.
|
| [11] |
朱巧红，毕光宇.非布司他治疗慢性肾衰竭合并高尿酸血症的临床观察[J].中国煤炭工业医学杂志，2015，18（12）：2042-2044.
|
| [12] |
陶小军，金星，陶沙，等.不同剂量非布司他对痛风伴高尿酸血症的效果及对内皮素-1水平的影响[J].中国全科医学，2014，17（2）：170-172.
|
| [13] |
Wells AF，Mac Donald PA，Chefo S，et al.African American patients with gout：efficacy and safety of febuxostat vs allopurinol[J].BMC musculoskeletal disorders，2012，13（1）：1.
|
| [14] |
台元名，王晓平.氨氯地平联合阿托伐他汀钙治疗高血压合并高血脂的临床疗效分析[J].黑龙江医药，2015，28（4）：826-827.
|
| [15] |
刘玉艳，李阅东，唐建飞，等.抗痛风新药非布司他的临床研究进展[J].中国新药杂志，2014，23（10）：1103-1106.
|
|
|
|
